NCT06762522 · NOT YET RECRUITING

Exploring Feasibility, Acceptability and Impact of Using Neurofeedback with Persons with Mild Cognitive Impairment

This pilot study is testing three different types of neurofeedback — a non-drug brain-training approach using real-time brainwave feedback — to see whether they are practical and acceptable for people with mild cognitive impairment, and whether five weeks of sessions might help with thinking, mood, or behavior. Phase NA means this is early exploratory work, not a test of an already-promising treatment. Details beyond the basics are limited so far.

You may qualify if

  • Adults with mild cognitive impairment (MCI) attending the Memory Clinic at Providence Care Hospital in Kingston, Ontario

You're excluded if

  • Adults with cognitive issues related to a psychiatric diagnosis or acute brain injury

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-01-07

View full record on ClinicalTrials.gov

All APOE4 clinical trials